ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000250.1|Nogalamycin_1 # 2 # 91 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.656	BGC0000250.1|Nogalamycin_1 	2	91	+	Loose	550	20.0162	APH(2'')-Ie	27.27	3002634	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATCTTCTCCCTGCCGATGTATCCCTCGCTGCCGCGGGAGACGCAGGACAGGGTGATCGAGGCCCTGCGCGAGGTGCTGGCGAAGGTGTGA	IFSLPMYPSLPRETQDRVIEALREVLAKV	MTTYTFDQVEEAIEQLYPDFTINTIEISGEGNDCIAYEINGNFIFKFPKHSRASINLLNEVTVLKTIHNELSLPIPEVVFTGMPSEMCQMSFAGFTKIKGVPLTPLLLKNLPKQSQDQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGHQMKKVDDFYRDILDNEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYMMKEKYWSFEKIIYGKEYGYMDWYEEGLNEIRSIKIK	9.63	gnl|BL_ORD_ID|119|hsp_num:0	137			291	390	amikacin; kanamycin A; tobramycin; gentamicin A; gentamicin
BGC0000250.1|Nogalamycin_2 # 152 # 1618 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.716	BGC0000250.1|Nogalamycin_2 	152	1618	-	Loose	700	27.335	ACT-51	25.58	3006246	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGACGAAACTGTCCGCCCACCCGGCCGCCCCCGCGCACGGTGCCGTGCCGGACCCGCTGCGGCTGGCTGCCTCGGCCCGCTCGGCGGGTGTGTGGCTGCCACGGACCACCGAGGTCCACCACTGGCTGGCCACGGTGGGGCAACACGCCCGGGCCCAGGTCGAGCGGGTCCCCCTGGCCGAGCTCGACGGCTGGCTCCGCGACCCGGCGACCGGCAACATCGCCCACCGCAGCGGGGGCTTCTTCACCGTGGAGGGGCTCGACGTGACCATCCCCCGGGCGCCCGTGCCGCACTGGGAGCAGCCGATCATCAACCAGCCCGAGGTCGGGCTCCTCGGCATCGTCGTCAAGGAGTTCGACGGCGTCCTGCACTGCCTCATGCAGGCCAAGCTGGAACCCGGCAACTGCAACGGCATCCAGCTGTCGCCTACCGTGCAGGCCACCCGCAGCAACTACACCCGGGTGCACCGCGGCCGGCCGGTGCCGTATCTGGAGCACTTCCAGGACCCCGCCCGCCGGAGCCGGATCCTGGCCGACGTGCGCCAGTCCGAGCAGGGCTCCTGGTTCCACCACAAACGCAACCGCAACATGGTCGTCGAGGTCGAGGAGGACATCGACGTCCACGACGGCTTCTGCTGGCTGTCGCTGGGCCAGCTCCACGAGCTGCTGACCGTGGACAACCTGATCAACATGGACACCCGTACGGTGCTGTCCTGTCTGCCCTTCGCCCACGCCGGCCTCGCGGCGGTGGCCGCCCCCGGCGCCGACCCGTTCCGCCGCGCGCTGGTCGCCTCCTGCGCTCCCGACGGCTACAGCCGGCACTCGCTGGGCGACCTGCTGAGCTGGATCACGGACGTGCGTACGCGCACCGAGGTGCGCACGGAGATGGTGCCGCTCGACGGCCTGCGGTCCTGGCGTCGCACGGACGAGCGGATCAGCCACGAGGACGGTGGCTTCTTCGATGTGATCGGCGTGCGGGTGCGGACGCGGGGGCGCGAGGTCGCCGAGTGGACCCAGCCGATGATCGAACCGCACGCCAAGGGCGTCGTGGCCTTCCTCGTCCGGCCCATCGAGGGCGTGCTGCACGTCCTGGTCCACGCGCGCGTGGAGCCCGGGTACGTCGACATCGTCGAGCTGGCGCCGACCGTGCAGTGCACACCCGACAGCTACGAACGGCTGCCGGCGCGGGCCCGCCCGCTCTTCCTCGACGAGGTTCTGCCGGCCCGGGCCGACCGAGTCCGCTTCGACGCCGAGCTCTCCGAGGAGGGCGGCCGCTTCTACCACGCGCGCAACCGCTACCTGGTGGCGGAGACCGACCTGGCCGCCGGCTTCGACCACCCCGACTTCCGCTGGGTGACGCTGGCCCAACTCGTGGAGCTGCTGCGGCACAGTCACTACGTCAACATCCAGGCGCGCAGTCTCGTCGCCTGCCTGTACGGCCTCGCCACGGCGCCGCCGAGGCGCTGA	MTKLSAHPAAPAHGAVPDPLRLAASARSAGVWLPRTTEVHHWLATVGQHARAQVERVPLAELDGWLRDPATGNIAHRSGGFFTVEGLDVTIPRAPVPHWEQPIINQPEVGLLGIVVKEFDGVLHCLMQAKLEPGNCNGIQLSPTVQATRSNYTRVHRGRPVPYLEHFQDPARRSRILADVRQSEQGSWFHHKRNRNMVVEVEEDIDVHDGFCWLSLGQLHELLTVDNLINMDTRTVLSCLPFAHAGLAAVAAPGADPFRRALVASCAPDGYSRHSLGDLLSWITDVRTRTEVRTEMVPLDGLRSWRRTDERISHEDGGFFDVIGVRVRTRGREVAEWTQPMIEPHAKGVVAFLVRPIEGVLHVLVHARVEPGYVDIVELAPTVQCTPDSYERLPARARPLFLDEVLPARADRVRFDAELSEEGGRFYHARNRYLVAETDLAAGFDHPDFRWVTLAQLVELLRHSHYVNIQARSLVACLYGLATAPPRR	MKTKSLCCALMLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKATHVSPGMLDAEAYGVKTNVQDMASWVKANMNPDALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKSYPNPARVEAAYRILSALQ	128.08	gnl|BL_ORD_ID|3104|hsp_num:0	4142			657	786	
BGC0000250.1|Nogalamycin_3 # 1615 # 2601 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.755	BGC0000250.1|Nogalamycin_3 	1615	2601	-	Loose	1200	31.5722	arnA	29.55	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCGCCGGGATACCGCGGACGGTGGCCGTCGTCGGCGCCACCGGCTGCGTCGGCCGGCACGTGTGCGACGCGTTCACGCGTGCCGGACACGACGTCGTGGCCCTCGCCCGCCGCGCGCCGGCCGGGCCCGGCCGCCACCCGCACCGGTTCTTGGCGTGCGACCCCGCCGGGCTCGCCCCGCGCGACCTCGCGGACCTCTTCCAGGACGCGCGCGTCGACACCGTCGTCAACGCCGCCGGCGGCTGGCTGAACACGGAGGACGACAACCGCTACCACCATGTGCGGCTGGTCGAGCGGCTGCTGGCGGGGACGGCCCTGATGGCGCGGACCCCGAGGCTGGTGCAGATCGGCTCCGTCCACGAGTACGGGCCCGTCCCCGCCGGCGACGCCGTCGACGAGAGCCGCGAACCACGCCCGGTGACGGTGTACGCCCGCACCAAGCACGCGGGCTCCCAGGCCGTACTGCGCGCCACGCGGGCCGGGGACGCCGACGGGGTCGTGCTGCGGGCCGTGAACGTGTGCGGCCCGTGGGTCACCCCGGCGAGCTTTCTCGGTACGGTGACGCGCCGGCTGAGCGAGGCCGCGCCGGGAGAGCCGGTGGAACTCACCCTCAGCGACGCGCGACGGGACTTCGTGGACGGGCGCGACCTCGCCGATGCGGTCCTACGGGCCGCGACCCGCCCGGTCACCGGCGAGATCTTCAACATCGGACGCGGTGAGGCCCTGCCGATCCGCTCCCTCGTCGCACTGCTGCTCGACGTGGCGGGGCTGCCCCCCGGCACCGTGAAGGAGCGCCTCCAGGAGGTCGCCTCACGGGGCGGCGACTGGACGCGGGTCGACACCCGGCGCGCGCGGCGGCTGCTGGGCTGGCGTCCTCGCATCGATCTGCGCACCTCTCTGCACGACATGTGGCGCGAGGCCCTGACGGGCCTGCCGCCGGCGACCGGCTCGCACGGCGACGGCTATCGGGAGTCAGCCTTATGA	MTAGIPRTVAVVGATGCVGRHVCDAFTRAGHDVVALARRAPAGPGRHPHRFLACDPAGLAPRDLADLFQDARVDTVVNAAGGWLNTEDDNRYHHVRLVERLLAGTALMARTPRLVQIGSVHEYGPVPAGDAVDESREPRPVTVYARTKHAGSQAVLRATRAGDADGVVLRAVNVCGPWVTPASFLGTVTRRLSEAAPGEPVELTLSDARRDFVDGRDLADAVLRAATRPVTGEIFNIGRGEALPIRSLVALLLDVAGLPPGTVKERLQEVASRGGDWTRVDTRRARRLLGWRPRIDLRTSLHDMWREALTGLPPATGSHGDGYRESAL	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.55	gnl|BL_ORD_ID|1513|hsp_num:0	1643			1536	1929	polymyxin B
BGC0000250.1|Nogalamycin_4 # 2598 # 3203 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.683	BGC0000250.1|Nogalamycin_4 	2598	3203	-	Loose	550	25.7942	IMI-5	37.14	3001862	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IMI beta-lactamase	ATGGAGTCACGCACGCTTCTCGTCGAGGGCGCCCACGCGTTCACGCCCCGGGTCTTCCCCGACGCCCGCGGATGCTTCGTCTCACCGTTCCAGCAGACCCCGGTGGCCGAGGCGCTCGGCCACCGGCTGTTTCCCGTGGCCCAGACCAATCACAGCCGGTCGCGGCGCGGCGTGGTACGCGGAGCGCACTTCACCCTCACCCCGCCGGGCATCGCCAAGTACGTCTACTGCGCCCGGGGACGGGCTCGCGACTACGTCATCGACATCCGTGTCGGCTCACCCACCTTCGGTCAGTGGGACTCGGTCGTCCTGGACGACCGGAACTTTCGCGCCATGTACTTCCCGGTCGGCGTGGCCCACGCCTTCGCCGCCCTGGAGGACGACACGGTGATGTCCTACATGCTCTCCGGCGAGTACGTGGCGGACAACGAACTGGCCCTGTCCGTCTTCGACCCCGATCTCGCCCTCGAACTTCCCGGGGACACGCCGTTGTTGCTCTCCGAGCGCGACACGGCGGCACCGACGCTCAGGGAACTGGAGTCGGACGGCCGGCTGCCGCGCTACGAGGAGTGCGTCAAGCTCGAACACGACCTGTACGCCGGATGA	MESRTLLVEGAHAFTPRVFPDARGCFVSPFQQTPVAEALGHRLFPVAQTNHSRSRRGVVRGAHFTLTPPGIAKYVYCARGRARDYVIDIRVGSPTFGQWDSVVLDDRNFRAMYFPVGVAHAFAALEDDTVMSYMLSGEYVADNELALSVFDPDLALELPGDTPLLLSERDTAAPTLRELESDGRLPRYEECVKLEHDLYAG	MSTTLRKSKPAFLLGSFLMSISLYSYANENGIDEIKNLEKKFNGRIGVYALDTGSGKSFAYRANERFPLCSSFKGFLAASVLKGSQDKQLNFSEIVNYNTRSLEPNSPITAKYKEQGMPLGEMAAAALQYSDNAATNIILERYIGGPVGMTKFMRSIGDEEFRLDRYELDLNTAIPGDERDTSTPEAVGKSLKNLALGNILNDSEKETYQTWLKGNTTGAARIRSSVPREWVVGDKTGTCGAYGTANDYAVVWPDDRAPLIISVYTTKYEKDAKHEEEFIAEASRIAIKTLN	68.84	gnl|BL_ORD_ID|3607|hsp_num:0	4676			468	555	
BGC0000250.1|Nogalamycin_5 # 3251 # 4222 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0000250.1|Nogalamycin_5 	3251	4222	-	Loose	450	26.9498	CVI-1	36.0	3006924	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CVI beta-lactamase	ATGACAGCCGGCGACACCACCCTCACCACCCACCGCACCGAACACCGCGTCACCGTCTCGGCACCCGCGCGGCGCGTCTTCGACCTGGTCGCGGACATCACAGGCTGGCCCCACACCTTCCCCCCGACCGTGCACGCGGAGTACGCCGAGCGCGGGGCGAGTGAGGAACGCATCCGCATCTGGGCCACGGCCAACGGCGAGGTCAAGGCCTGGACCTCGCACCGCTCGCTGGACCGGGAAGGGCTGCGCGTCCGCTTCCGGCAGGAGAAGTCCCAGCACCCCGTGGCCGGCATGGGCGGCGAGTGGATCATCCGGCCGGTGGACGGCGAGCGGAGCGAGGTGATCCTCACCCACGACTTCCAGGCCGTGGAGGACGACCCGGCCCACGTGGACTGGATCCACCGTGCCGTGGACCGCAACAGCGGCGCCGAACTCGCGGCGCTGAAACCGCGGCGGAACGCGCGGACGGCGCGGAACGGCACCCTGTTCACCTTCGCCGACGAGGTCACCGTCACCGGTGCCCCCGGTGACGTCTACGACTACCTCAACGAGGCCCGGCGCTGGCAGGAGCGCCTCCCGCACGTCGCCGCGGTGAGCCTCGACGAGCCCGCCCCCGGAGTGCAGCGGCTCGGCATGGACACCAAGGGACCCGACGGAACCGTGCACACCACCGAGTCGGTCCGCATCTGCTTCCCCCAGGACCGCATCGTCTACAAGCAGTTCACGATGCCACCGCTGATGGCCGTCCATACCGGCACATGGCGGATCGCACCCGCCGCGGACGGCCACGGCACGACCGTCACCTCCCTCCACACCGTCGTGGTCGACGACAGCGCCGTCACCACCGTCCTGGGCCCGGACGCCACCCTCGCCGACGCCCGCCGCTTCCTGCGTGACGCCCTCGGCCGCAACAGCCGTACCACCCTCGGCTTCGCCAAGGAATACGCCGAGGAGCGCGCGCGGCGGGCCTGA	MTAGDTTLTTHRTEHRVTVSAPARRVFDLVADITGWPHTFPPTVHAEYAERGASEERIRIWATANGEVKAWTSHRSLDREGLRVRFRQEKSQHPVAGMGGEWIIRPVDGERSEVILTHDFQAVEDDPAHVDWIHRAVDRNSGAELAALKPRRNARTARNGTLFTFADEVTVTGAPGDVYDYLNEARRWQERLPHVAAVSLDEPAPGVQRLGMDTKGPDGTVHTTESVRICFPQDRIVYKQFTMPPLMAVHTGTWRIAPAADGHGTTVTSLHTVVVDDSAVTTVLGPDATLADARRFLRDALGRNSRTTLGFAKEYAEERARRA	MRTVFGFAGALLGLAAAACAAQGGLALKHLKGGVYVVEDGYYAKENSVVYVGAEHVTVVGATWTPDTARELARQIRAVTYKPIAEVVNPNYHPDRAGGNAYWKSIGARIVSTRQTADEMRRGWDEVVAFTRRGFPDYPALPVSLPDREHPGDFELQDGRIKAFHLGAAHTRDGIFIHFPQERVLYGNCILKQELGNLSYADLNEYPKTLERLKLSELDFDTVIAGHLDALHGPELIDHYQRLLKRQASDAAAERS	126.67	gnl|BL_ORD_ID|3506|hsp_num:0	4575			495	570	
BGC0000250.1|Nogalamycin_6 # 4283 # 5071 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.695	BGC0000250.1|Nogalamycin_6 	4283	5071	-	Loose	2300	27.7202	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin	26.28	3003283	protein variant model	D441V	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGCCGGACACGGACGGGCGGGTCGCCGTCGTCACAGGCGGCACCAGCGGGATAGGACTCGCGGTGGTGAAGGCACTGGCTGCGACAGGATATGCGTGTCGTTCCCTGTGTGCCCGGAGCCAGGACGCCGTCGACAGCACCGTGGAGGAGCTGCGCGACGAGAAGCTGGAGGTGGACGGGCGCTCCTGCGACGTGCGTTCCACGGACGACGTACGGGAGTTCATCGGCTTCGCCACGCGGCGCTTCGGCGGCGTGGACGTGCTGGTCAACAACGCCGGCCGCAACGGCGGAGGCCCGACCGCGCGGATAACCGACGAGCTGTGGCTCGACGTCATCGAGACCAACCTCACCAGCGTCTTCCGCGTCACCCGCGAGGTGCTGACCACCGGAGGGATGCTCGCCGCCGGACGCGGCAGGATCATCAACATCGCCTCCACCGGCGGCAAACAGGGTGTCGTCCTCGGTGCCCCGTACTCGGCCTCCAAGCACGGCGTCGTCGGCTTCACCAAGGCACTGGGCCTGGAGCTGGCCAAGAGCGGCATCACCGTCAACGCCGTCTGCCCGGGCTATGTCGAGACTCCCATGGGCGAGCGGGTCGGTCGCGGCTACGCCGAGGTCTGGGACACCTCCGAGGAGGCGGTGCTGGAGCGCTTCCAGGCGAAGATCCCGCTCGGCCGCTACGCGCAGCCCGAGGAGGTCGCCGGCCTCGTCACCTACCTGACCACGCCCACCGCCGACTCCATCACCGCGCAGGCGCTCAACGTCTGCGGCGGCCTGGGAAACTACTGA	MPDTDGRVAVVTGGTSGIGLAVVKALAATGYACRSLCARSQDAVDSTVEELRDEKLEVDGRSCDVRSTDDVREFIGFATRRFGGVDVLVNNAGRNGGGPTARITDELWLDVIETNLTSVFRVTREVLTTGGMLAAGRGRIINIASTGGKQGVVLGAPYSASKHGVVGFTKALGLELAKSGITVNAVCPGYVETPMGERVGRGYAEVWDTSEEAVLERFQAKIPLGRYAQPEEVAGLVTYLTTPTADSITAQALNVCGGLGNY	MADSRQSKTAASPSPSRPQSSSNNSVPGAPNRVSFAKLREPLEVPGLLDVQTDSFEWLIGSPRWRESAAERGDVNPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDDVKAPVDECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLVRSPGVYFDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKALGWTSEQIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLFFKEKRYDLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATIEYLVRLHEGQTTMTVPGGVEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINIRPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHYGRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIVYLTADEEDRHVVAQANSPIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVVVAEESGVIEEVSADYITVMHDNGTRRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVIADGPCTDDGEMALGKNLLVAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNISDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILPVEDMPFLADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHSGWKVDAAKGVPDWAARLPDELLEAQPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLVDADGKAMLFDGRSGEPFPYPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSSDGAAIELREGEDEDLERAAANLGINLSRNESASVEDLA	22.35	gnl|BL_ORD_ID|1957|hsp_num:0	1237			1056	1467	rifampin; rifaximin; rifabutin; rifapentine
BGC0000250.1|Nogalamycin_7 # 5321 # 6181 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0000250.1|Nogalamycin_7 	5321	6181	+	Loose	500	30.4166	ErmH	53.33	3002823	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGACACGGCGGAATACAAGCAGACCGTAACCGCGGCCTTCGACCGCGCGGCGGCGCACTACGACCGGCTGGGGGTCGAGTTCTTCACCCCCATGGGACTCCGGCTGGTGGATCACGCGGATCCCCGGCCGGGCCAGCGGGTGCTCGACGTCGGCTGCGGGCGCGGCGCCTGTCTGTTCCCCGCGGCCCGGCGCGTCGCTCCGGACGGCTATGCCCTCGGCATCGACATCGCGCCGGCGATGGTCGAGGAGGCGGCCGCGGAGGCCGAACGGCTGGGCATGCCGCATGTCGAGGTGCGTGTCATGGACGGGGAGCGCCCCGCTCTGCCGGAACGCTCCTTCGAGCGGGTGCTGGGCAGCTACAGCGTGATCTTCTTCCCGGAGGCGCTGCCCGCTCTCGTCCGCTATGCCGGGCTGTTGGCGGACGGGGGGCGCATCGCGTTCACCAGCCCGGTGTTCACCGAGGACACCTTTCCCTTCCTGCCCCCCGTGTTCACGGAGCTGATCCCGCGCTCCCTGCTGGACACCCTCCCGCCCGACTGGCGGCCGGAGGCACTGCGCCGACGGTTCAACAGCTGGCTGGAGCGGCCCGACGATCTGGAAGCGACGATGCGCCGGGCGGGATTCGGCGAGGTGGGCATCACCGACGAGACGGTCCCGATGGTGGCCGTCTCCGGGGAGGCCTGGGTGGACTGGTCCCACACCAACGGCATGCGGCTGTTGTGGCAGCACCTGCCGCGGGACGAGGCGCAGCGGCTACGGGAGCGGCTGATCACGGAGCTGGACGCGATGCGTCGGGCCGACGCACCGCTGTCCATCCCGGTACCGGTGCGCTTCGTCACGGCGGTGGTGGACCGGTGA	MDTAEYKQTVTAAFDRAAAHYDRLGVEFFTPMGLRLVDHADPRPGQRVLDVGCGRGACLFPAARRVAPDGYALGIDIAPAMVEEAAAEAERLGMPHVEVRVMDGERPALPERSFERVLGSYSVIFFPEALPALVRYAGLLADGGRIAFTSPVFTEDTFPFLPPVFTELIPRSLLDTLPPDWRPEALRRRFNSWLERPDDLEATMRRAGFGEVGITDETVPMVAVSGEAWVDWSHTNGMRLLWQHLPRDEAQRLRERLITELDAMRRADAPLSIPVPVRFVTAVVDR	MAALLKRILRRRMAEKRSGRGRMAAARTTGAQSRKTAQRSGRSEADRRRRVHGQNFLVDRETVQRFVRFADPDPGEVVLEVGAGNGAITRELARLCRRVVAYEIDRHFADRLREATAEDPRIEVVAGDFLKTSQPKVPFSVVGNIPFGNTADIVDWCLNARRLRTTTLVTQLEYARKRTGGYRRWSRLTVATWPEVEWRMGERISRRWFRPVPAVDSAVLRLERRPVPLIPPGLMHDFRDLVETGFTGKGGSLDASLRRRFPARRVAAGFRRARLEQGVVVAYVTPGQWITLFEELHGR	95.65	gnl|BL_ORD_ID|1100|hsp_num:0	1193			192	282	erythromycin; lincomycin; pristinamycin IC; oleandomycin; carbomycin
BGC0000250.1|Nogalamycin_8 # 6221 # 6577 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.689	BGC0000250.1|Nogalamycin_8 	6221	6577	-	Loose	1000	24.6386	MCR-5.3	40.0	3007282	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGCCGACACGAGTGAACGATGGCGTCGACGCGGACGAGGTCACCTTCGTCAACAGGTTCACCGTCCACGGGGGGCCCGCGGAGTTCGAGAGCGTCTTCGCACGGACCGCGGCCTTCTTCGCGCGGCAGCCCGGGTTCGTCCGGCATACGCTGCTGCGCGAGCGGGACAAGGACAACAGCTATGTGAACATCGCCGTCTGGACCGACCACGACGCCTTCCGGCGGGCCCTGGCCCAGCCCGGGTTCCTGCCGCACGCCACCGCGTTGCGGGCCCTGAGCACCAGCGAACACGGGCTGTTCACGGCGCGCCAGACACTGCCGGAAGGCGGCGATACGACCGGCTCCGGACATCGCTGA	MPTRVNDGVDADEVTFVNRFTVHGGPAEFESVFARTAAFFARQPGFVRHTLLRERDKDNSYVNIAVWTDHDAFRRALAQPGFLPHATALRALSTSEHGLFTARQTLPEGGDTTGSGHR	MRLSAFITFLKMRPQVRTEFLTLFISLVFTLLCNGVFWNALLAGRDSLTSGTWLMLLCTGLLITGLQWLLLLLVATRWSVKPLLILLAVMTPAAVYFMRNYGVYLDKAMLRNLMETDVREASELLQWRMLPYLLVAAVSVWWIARVRVLRTGWKQAVMMRSACLAGALAMISMGLWPVMDVLIPTLRENKPLRYLITPANYVISGIRVLTEQASSSADEAREVVAADAHRGPQEQGRRPRALVLVVGETVRAANWGLSGYERQTTPELAARDVINFSDVTSCGTDTATSLPCMFSLNGRRDYDERQIRRRESVLHVLNRSDVNILWRDNQSGCKGVCDGLPFENLSSAGHPTLCHGERCLDEILLEGLAEKITTSRSDMLIVLHMLGNHGPAYFQRYPASYRRWSPTCDTTDLSSCSHEALVNTYDNAVLYTDHVLARTIDLLSGIRSHDTALLYVSDHGESLGEKGLYLHGIPYVIAPDEQIKVPMIWWQSSQVYADQACMQTHASRAPVSHDHLFHTLLGMFDVKTAAYTPELDLLATCRKGQPQ	21.57	gnl|BL_ORD_ID|4894|hsp_num:0	5887			1266	1380	colistin A; colistin B
BGC0000250.1|Nogalamycin_9 # 6684 # 8600 # -1 # ID=1_9;partial=00;start_type=TTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.709	BGC0000250.1|Nogalamycin_9 	6684	8600	-	Loose	450	30.8018	baeR	28.68	3000828	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGAATTTCGACTGCTGGGTCCGGTTGAAATACTCTGGCAGGGGCGCAACATCATGCCGACGGCTCCCAAGCCGCGGCAGGTCATATCCCTTCTGATGCTCCGTCACAACACAGTCGTGCAGGCTGCGGAGCTGATCGACGAATTATGGCCGGAGCTGCCGCCGCCGAGCGCGATCACCACCCTCCAGACCTACATCTACAAATTCCGGAAGATTCTCATGAAGCAGGGGGCCGATGATCTTCTGCGTACCCAGCCGGGCGGATACATCCTGACGATCCCGCCCTCCACCGTCGACGTCAACCGGTTCGAACGGGACGCCGACGACGGGCAGGAACTGCTGCAGCGCGGTGACGCCGCCGGCGGGACGAAGCTCGGCCACGCCCTGGCCCTGTGGCGGGGCCCAGCACTGGCCGATGTCGTCGCCAGCGGACGCCTGTTCTCGTACGTCACGCGGCTGGAGGAGCTGCGGTTTCGCATCCTCGAACTGCGCATCGAGGCGGACCTCGCGACCGGGCGGCACCGGGAACTCGTGAGCGAGCTGAAATCGCTGGTACTGGCACACCCCCTCCACGAGCACCTGCACGGGCTGCTGATGCTGGCCCTGCACCGGTCGGGGCGGCCCCACGAGGCGTTGGAGGTCTACCGGAGCGTACGCCACAAGATGATCGAGGACCTCGCCCTGGAACCCGCCCAGGACTTCGCCACTTTGCACCACACCCTGCTGTCCGACTCCCCGCCCGAGGCACCCGAACCCCTCTGGCCGGCACAGCACCTGACGACCAAGCAGCCGGAACGCGTCACCATCGCCCGCGAACCAGCCCCGGACACCGCCCCCAGCCCGCTGGCCAGACCGGCCCAATTGCCCGCCGACATCGTGGACTTCGTCGGCCGACGGGCGGTGCTGGACCGGCTCGTCGGTGTGCTGGCACAACCCGGCGGCAGCCGCGATGCCGGGCGCACGGCGGTCCGGGTCGGCGTGGTGACCGGTGCGCCGGGCGTGGGCAAGAGCGTGCTGGCCGTGCACGCGGCGCACACGCTGCGCCCGCGCTATCCCGACGGGCAGCTCTACGCCGACCTGCGCGGCTCCTCGTCCGAACCCCGCGACCAGTCCGAGGTGCTGGCGGGCTTCCTGCGGGCCCTCGACATCCCGCCCGCCCGGATCCCGGACCGGTTGGAGGAACGCGGCGCGCTGTTCCGTTCCTGCACGGCCGGACGCAGGGTGCTTGTCCTGCTCGACGACGTGGCCTGTTCGCCACAGGTGCGGCATCTGCTGCCCGGCGACCCGCACTGCGCGCTGCTGGCCACCGGCCGGCGCCGTATGCCCGGGCTGGTGGAGGCCTCGCACGTCGAACTCGGCCTGCCCGGCAGAACCGAGGGCCGGGAGATGCTGGCCCGTGTGCTGGGCAGGCAGCGGGTGGAGCGGGAACCCGCGGCGGCCGACACCATCGTCACGCTCCTCGGCCACCACCCACTGGCGCTGCGCTGCGTCGCGGGACGCTCACGGCGATGCCGGGGCTGTCCCTGGAGGCCATGGCCGAGGCAGCTCGACACCGCGCCCCGCATCCTGGACGCGGCCCGGCTGGGCGAACTCGACGTACGGTCCCGGTTCGATCTGAGCTACGAGGGCCTCAGCCCGGTGGAGCAGGGGGTGTTCCGGCTGCTGAGCATGTTGGAGAGCTCCCCGTTCACCGTCGCGCAGGCCGCGGGGCTGTTGGGGTGGAGAAGCGCCGACATACAGCCCGTACTGGAGGCACTGGCCGACAACCACCTGCTCAGCGCAGGACCGGGCGGGGGGACGGCGCCGCCCGCTACTCCTACCCACGGCTCACCCTGGCGTACGCCGGGGGAGCGCTTGGAGGCGACGCTGTCCCAGCCCCGCGCCGTCGAGGGTGCCGGCGCCGCCAGCGCCGTCTGA	MEFRLLGPVEILWQGRNIMPTAPKPRQVISLLMLRHNTVVQAAELIDELWPELPPPSAITTLQTYIYKFRKILMKQGADDLLRTQPGGYILTIPPSTVDVNRFERDADDGQELLQRGDAAGGTKLGHALALWRGPALADVVASGRLFSYVTRLEELRFRILELRIEADLATGRHRELVSELKSLVLAHPLHEHLHGLLMLALHRSGRPHEALEVYRSVRHKMIEDLALEPAQDFATLHHTLLSDSPPEAPEPLWPAQHLTTKQPERVTIAREPAPDTAPSPLARPAQLPADIVDFVGRRAVLDRLVGVLAQPGGSRDAGRTAVRVGVVTGAPGVGKSVLAVHAAHTLRPRYPDGQLYADLRGSSSEPRDQSEVLAGFLRALDIPPARIPDRLEERGALFRSCTAGRRVLVLLDDVACSPQVRHLLPGDPHCALLATGRRRMPGLVEASHVELGLPGRTEGREMLARVLGRQRVEREPAAADTIVTLLGHHPLALRCVAGRSRRCRGCPWRPWPRQLDTAPRILDAARLGELDVRSRFDLSYEGLSPVEQGVFRLLSMLESSPFTVAQAAGLLGWRSADIQPVLEALADNHLLSAGPGGGTAPPATPTHGSPWRTPGERLEATLSQPRAVEGAGAASAV	MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV	265.83	gnl|BL_ORD_ID|1231|hsp_num:0	1337			375	687	novobiocin
BGC0000250.1|Nogalamycin_11 # 10694 # 11956 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.754	BGC0000250.1|Nogalamycin_11 	10694	11956	+	Loose	680	28.4906	LpeA	27.03	3004099	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCGGTCCGGGCTCGCGGGGAAGGTCGGCCGCGTGACGGCCGCCGTGGTGGTGACCGGTCTCGGCGTCGTCGCCCCCACCGGTCTCGGGGTGCGGGAGCACTGGTCGAGTACGGTCCGGGGGGCGTCGGCGATCGGACCGGTCACCCGGTTCGACGCCGGCCGGTACCCCAGCAAACTGGCCGGAGAGGTGCCCGGTTTCGTCCCGGAGGACCATCTGCCCAGCCGGCTGATGCCGCAGACGGACCATATGACGCGCCTGGCGCTCGTCGCGGCGGACTGGGCCTTCCAGGACGCCGCCGTGGACCCGTCGAAGCTGCCGGAGTACGGCGTCGGCGTGGTCACCGCGAGTTCGGCGGGGGGGTTCGAATTCGGCCACCGCGAGCTGCAGAACCTGTGGAGCCTGGGCCCGCAGTACGTCAGCGCGTATCAGTCGTTCGCATGGTTCTATGCCGTGAACACCGGTCAGGTGTCCATCCGGCACGGGCTGCGCGGCCCGGGCGGGGTGCTGGTGACGGAACAGGCGGGCGGCCTGGACGCCCTTGGGCAGGCCCGGCGGCAGTTGCGGCGCGGACTGCCGATGGTGGTCGCGGGAGCCGTTGACGGCTCGCCCTGCCCCTGGGGCTGGGTGGCGCAGCTCAGCTCGGGCGGCCTCAGCACGTCGGACGACCCGCGCCGGGCCTATCTGCCGTTCGACGCCGCAGCCGGCGGACACGTGCCGGGAGAGGGCGGCGCCCTGCTCGTCCTGGAGAGCGACGAGTCGGCCCGGGCGCGCGGGGTGACGCGGTGGTACGGGCGCATCGATGGGTACGCCGCCACATTCGACCCCCCGCCCGGTTCGGGGCGCCCGCCGAACCTGCTGCGGGCCGCGCAGGCGGCACTGGACGACGCGGAGGTCGGACCCGAGGCGGTCGACGTGGTGTTCGCGGACGCGTCCGGCACCCCGGACGAGGACGCGGCGGAGGCCGACGCGGTGCGGCGCCTGTTCGGACCGTACGGCGTTCCGGTGACGGCGCCGAAGACCATGACCGGCCGCCTCAGCGCGGGCGGCGCGGCCCTCGACGTGGCGACGGCGCTGCTGGCGCTGCGCGAGGGCGTCGTCCCGCCGACGGTCAACGTCTCCCGGCCGCGGCCGGAGTACGAGCTGGACCTGGTGCTCGCCCCCCGGCGCACGCCCCTGGCCAGGGCCCTGGTGCTCGCGCGGGGCCGGGGCGGGTTCAATGCGGCGATGGTCGTGGCGGGGCCGCGCGCGGAGACACGGTGA	MRSGLAGKVGRVTAAVVVTGLGVVAPTGLGVREHWSSTVRGASAIGPVTRFDAGRYPSKLAGEVPGFVPEDHLPSRLMPQTDHMTRLALVAADWAFQDAAVDPSKLPEYGVGVVTASSAGGFEFGHRELQNLWSLGPQYVSAYQSFAWFYAVNTGQVSIRHGLRGPGGVLVTEQAGGLDALGQARRQLRRGLPMVVAGAVDGSPCPWGWVAQLSSGGLSTSDDPRRAYLPFDAAAGGHVPGEGGALLVLESDESARARGVTRWYGRIDGYAATFDPPPGSGRPPNLLRAAQAALDDAEVGPEAVDVVFADASGTPDEDAAEADAVRRLFGPYGVPVTAPKTMTGRLSAGGAALDVATALLALREGVVPPTVNVSRPRPEYELDLVLAPRRTPLARALVLARGRGGFNAAMVVAGPRAETR	MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS	118.31	gnl|BL_ORD_ID|2386|hsp_num:0	2758			354	576	erythromycin; spiramycin; azithromycin
BGC0000250.1|Nogalamycin_12 # 12016 # 12276 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.705	BGC0000250.1|Nogalamycin_12 	12016	12276	+	Loose	150	23.8682	nimE	28.12	3007107	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	GTGAAGCAGCAGCTGACGACGGAACGGCTCATGGAGATCATGCGGGAGTGCGCGGGCTACGGTGAGGACGTCGACGCTCTGGGCGACACGGACGGCGCCGACTTCGCCGCACTCGGCTACGACTCGCTGGCGCTCCTGGAAACGGCCGGCCGGCTCGAGCGCGAGTTCGGCATCCAGCTCGGTGACGAGGTGGTCGCCGACGCCAGGACGCCTGCCGAGCTGACCGCCCTGGTCAACCGGACGGTGGCCGAGGCGGCCTGA	MKQQLTTERLMEIMRECAGYGEDVDALGDTDGADFAALGYDSLALLETAGRLEREFGIQLGDEVVADARTPAELTALVNRTVAEAA	MFREMRRKRQLLPQEESVAILEKMTNGTLALHGDNGYPYAVPLSYFYADGKIYFHCAKIGHKVDAIMQNNKVSFCVVEQDNIKPAEFTTYFRSVIVFGKAYILTDETEKRMAMTLLVNKYSFGEPGLSDEIAKSINHLLMVKIDIEHMTGKEAIDLVREKEKFCTSEKTS	50.59	gnl|BL_ORD_ID|4784|hsp_num:0	5780			150	246	metronidazole
BGC0000250.1|Nogalamycin_13 # 12300 # 13037 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.724	BGC0000250.1|Nogalamycin_13 	12300	13037	+	Loose	400	35.039	Erm(30)	29.41	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGACGCGTGTGTACGGCACGGAACTCACACAGATCTACGAACTGGTCCACGAGGGCCGCGGCAAGGATTACGGAGCGGAGGCCGAGGAGATCACCCGCCGGATCCGGGCGCGGTTGCCCGGGGCGCGGACGCTGCTCGATGTCGCCTGCGGCACGGGCGCGCACCTGCGGGCGTTCGCGACGCGATTCGAGGAGGTGGAGGGGGTGGAACTGTCCGAGGCGATGTGCGCGGTCGCGCGCCGCCGCCTGCCCGGAGTGGCCCTGCACCGGGCGGACATGCGCGACTTCCGGCTCGGCCGGACGTTCCACGCCGTCACCTGCATGTTCGGCTCGATCGGCTACGCCCGTACGCCGCAGGAGCTCACGGCGACGCTGCGCTGCTTCGCCGCGCACCTGGCGCCCGGCGGGGTGGCCGCGGTCGACCCGTGGTGGTTCCCGGAGACGTACCTGGACGGGTATGTCTCGGGCGACACCATGACCGTGGACGGGCGGACGGTCTCCCGCGTCTCCCACTCGACGCGCGAGGGCACCGCCTCGGTGATGCGGGTGCACTACCTGGTGGCGGACGCCGCCTTGGGCGTGCGCCACTTCTCGGAGTCGCACCGCATCTCGCTGTTCTCCCGCGAGCAGTACGAGGAGGCCTTCTCGCGGGCGGGGTTCGCGGTGGAGTACGTCCCGCGGCTGCACGCGGGGCGCGGACTGTTCCTCGGTGTCCGGAAGTCCGGGCGGGCGGGGTGA	MTRVYGTELTQIYELVHEGRGKDYGAEAEEITRRIRARLPGARTLLDVACGTGAHLRAFATRFEEVEGVELSEAMCAVARRRLPGVALHRADMRDFRLGRTFHAVTCMFGSIGYARTPQELTATLRCFAAHLAPGGVAAVDPWWFPETYLDGYVSGDTMTVDGRTVSRVSHSTREGTASVMRVHYLVADAALGVRHFSESHRISLFSREQYEEAFSRAGFAVEYVPRLHAGRGLFLGVRKSGRAG	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	72.92	gnl|BL_ORD_ID|1123|hsp_num:0	1224			126	372	narbomycin; methymycin; pikromycin
BGC0000250.1|Nogalamycin_14 # 13083 # 14117 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=11-12bp;gc_cont=0.691	BGC0000250.1|Nogalamycin_14 	13083	14117	-	Loose	750	26.9498	PDC-77	24.74	3004340	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGGCCGGCGTCCTCCTCGCGGAGGTCGCGTTCCGCTGCCCGCCGCCGGTCAACACGCTCCCCGTCCACGTGGGCCTCGATCTCGAACACGACGGTGCGGTGCGGCGCTCGGCCCTGCGGCTGGTCCGGGACGAACCGGTGACCGTCCACCCACGCCCGCAGGAGGGCACCCCCACACTGCTGCGCTTCAGCCTCGCAGACTTGGTACGGCGGTTGTTCGGTCCCGAGGAAGCCGGCCAGGGCGGGGACTTCCACAACGAGTTCCTGCCGCAGCCACCCGGTGCCGAGAACATGATGGAGACCTGGAGCGCCGTCTCCCACGCGACCCACACGGTGATGACCGCGCTCTCCACCCTCACCCCCGATCTCGGTGAACTCGCCGTCCGGTACGGCTCCGACAAGTGGGCCAGCTTCCACTGGTACACCCCGCACTACGACCACCATTTCCGCCCACTGCGGAACACGCCCGTCCGTGTGCTGGAGATCGGCGTCGGCGGCTACGAGGAGTACGACGGCGGCGGCTCGCTGAAGATGTGGAAGCGCTACTTCCGGCGCGGCCTGATTCACGGTCTCGACATCGTCGACAAGACGCGGCTGAGCGAGCCCCGGCTGACCGTGCTCACCGGCGACCAGAACGACCCGGAGACGCTGGAGCGGATCGTCCGCGAGCACGGACCGTTCGACGTCGTCATCGACGACGGAAGCCACGTCAACCAGCACGTCCACACGTCGTTCCGCACCCTCTTCCCGCACCTGCGGTCCGGCGGGCTGTACGTGATCGAGGACCTGCAAACCTCGTACTGGCCCGAGTTCGGGGGCACCGACGGCCCCAACGCCGCCCCGGACACCTCCCTGGGCCTGGTCAAACAACTGCTGGACGACCTGCACCACCAGGAGCGCCCCAAGGACCGCGACACGGCGGACGCGACGCGGAGCACGGTCACCGGCGTGCACGTGTACCACAACATCGCCTTCGTCACGAAGGGCGTCAACGGCGAGGCCCCGCTGCCCGACTGGATGCTCCAGGGGCACTGA	MAGVLLAEVAFRCPPPVNTLPVHVGLDLEHDGAVRRSALRLVRDEPVTVHPRPQEGTPTLLRFSLADLVRRLFGPEEAGQGGDFHNEFLPQPPGAENMMETWSAVSHATHTVMTALSTLTPDLGELAVRYGSDKWASFHWYTPHYDHHFRPLRNTPVRVLEIGVGGYEEYDGGGSLKMWKRYFRRGLIHGLDIVDKTRLSEPRLTVLTGDQNDPETLERIVREHGPFDVVIDDGSHVNQHVHTSFRTLFPHLRSGGLYVIEDLQTSYWPEFGGTDGPNAAPDTSLGLVKQLLDDLHHQERPKDRDTADATRSTVTGVHVYHNIAFVTKGVNGEAPLPDWMLQGH	GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPRPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	92.72	gnl|BL_ORD_ID|2464|hsp_num:0	2856			621	831	
BGC0000250.1|Nogalamycin_15 # 14574 # 15809 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.747	BGC0000250.1|Nogalamycin_15 	14574	15809	+	Loose	700	52.7582	oleI	31.5	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	GTGCGCGTCATGTTCACCGTCTCCTCCTGGCCCACCCACTACGCCTCCCTCGTCCCCCTCGGCTGGGCGCTGCAGGCCGCCGGGCACGAGGTACGGGTGCTGTGCGCCCCGTCGCAGACCGACTCCGTCGCGCACGCGGGCCTGACTCCCGTACCGGTGCTCGACGGGCTCGACGTGCCGCAGTGGCTGCGACTGCAGTACTACGAGGAGGCACGCCAGGGCATCTGGCCGTATCCGTGGCTGCCGCCGCATCCGGTCACCGGGGAGGACATGGCCGCCCTGGACGAATTCGACATGGCCGAGTACCGGGCCACCACCGGCGCCGAGCAGGCCGCGCGGGCCGCCCGGGGCTTCGACGCCGCCCTCGCCCTGGCCCGGGAGTGGGCGCCGCACCTGGTGCTCCATGACCCGGTGAGCCTGGAAGGGCTGCTGGCCGCGCGCGTACTCGGTGTGCCGTCCGCGCTCTGTCTGTGGGGGCCGGTCGGTCCCCACGAGCCCGAGCACATGCGCGTCGTGCCGGACGACCACAGCGGTTCCTTCGCCCGTCACGGCCTCGGCGCGTTCCATCTCGGCATGATCGAGCGCGTCGTCGACCCCTGCCCGGCCACCCTGGAGCCCAAGGCGGAGGCCCCCCGGCTGCCGGTGCGCTACGTCCCTTACAACGGCGGCGGCCACGCGCCGGACGTGTCGCTGCTCTCCGCACCGCCCGGGCCGGGCGCCCGGCCGCGGATCCTGCTGACCTGGTCGACCGCGCTGTCCATGATCTCCGGGCCCCGGTCCTACGCGCTGCCCGGCCTGGTGCGCGCTCTCGAGGGGGTCGGCTGCGAGCTCCTGGTGACCGCGACGGCCCGGGACCTGGCGGCGCTCGGACCCGTGCCGGACTCGGTGCGGGTGCTGGAGCGCGCACCGCTGCGGCTGCTCGCCCCGGCCTGCGACCTGATCGTGCACCACGGTGGCAGCGGCAGCACGCTGACCTCGCTGTGGGCGGGAGTGCCTCAGCTGTTCCTCACCTTCGCCTCCGAACAGGCCGCCACCGCCACCCGGGTGGCCACCGCCGGAGCGGCACGGCACCTGCCAGGGCACCAGGCCGACCCGGCGACGGTGCGCGCGGCCGTGACCGAGCTGCTCCAGGACACCTCCTACCGCCGGTCCGCCACCGCGTTACGCGAGGAAATGTTCAGCCGGCCCTCCCCGGCCGAGCTGGTGACGACGCTGGAGGCACTGGCGGCGGGGTGA	MRVMFTVSSWPTHYASLVPLGWALQAAGHEVRVLCAPSQTDSVAHAGLTPVPVLDGLDVPQWLRLQYYEEARQGIWPYPWLPPHPVTGEDMAALDEFDMAEYRATTGAEQAARAARGFDAALALAREWAPHLVLHDPVSLEGLLAARVLGVPSALCLWGPVGPHEPEHMRVVPDDHSGSFARHGLGAFHLGMIERVVDPCPATLEPKAEAPRLPVRYVPYNGGGHAPDVSLLSAPPGPGARPRILLTWSTALSMISGPRSYALPGLVRALEGVGCELLVTATARDLAALGPVPDSVRVLERAPLRLLAPACDLIVHHGGSGSTLTSLWAGVPQLFLTFASEQAATATRVATAGAARHLPGHQADPATVRAAVTELLQDTSYRRSATALREEMFSRPSPAELVTTLEALAAG	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	96.93	gnl|BL_ORD_ID|1684|hsp_num:0	1824			885	1263	oleandomycin
BGC0000250.1|Nogalamycin_16 # 15813 # 18152 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.701	BGC0000250.1|Nogalamycin_16 	15813	18152	-	Loose	650	59.3066	tetA(58)	35.03	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCCTCCGTGACGACACCGACGGCACCCGGGGCGGACCCGGCACCGACCCGGCGGACAGCCACGATGTGATCCAGGTGCGGGGCGCGCGCGAGAACAACCTGAAGAGAGTCTCCCTGGACATCCCCAAACGGCGTCTGACGGTCTTCACCGGCGTCTCCGGCTCCGGTAAGTCCTCCCTGGTCTTCGACACCATCGCCGCCGAGTCCCGGCGGCTGATCAATGAGACGTACACCGCGTTCATCCAGTCGTTCCTGCCGGCCCTCGCGCGGCCCGACGTCGACGGGCTGCACAACCTCAGCGCCGCCATCGTCGTCGACCAGGAGCGCATGGGGGTCAACTCCCGCTCCACCGTGGGCACCGCCACCGACGCGCTGGAGATGCTGCGGATCATCTTCAGCAGGCTCTCCACCCCGCACGTGGGCGGCCCCGGCGCCTTCGGTTTCAACAGCCCCGACGGCATGTGCCGGCACTGTGAGGGCCTGGGGCGTGTCGCCGACATCGACGTCGATCAACTCGTCGACAGGGAGCGCTCCCTGAACGAAGGGGCGATCACCGTGCCGGGCTACGCCGTCGGCTCCTGGAACTGGCAGATCTTCGCCGAGTCGGGCCTGCTCGACCCCGACCTCAGGCTCCGGGACTACAGCCCCGACCAGTGGCACGACCTCATGCACAAGCCCGCCACGAAGATCAGGCACAACAGCCTCAACGTCACCTACGAGGGGCTGCTGGTGAAGGTGCGCCGCACACACCTCGCCAAGGAACGGGAGTCCATGCAGGCGCACATCCGGGCCTTCGTGGAGCGGGCCGTGGTCTTCGGCCCCTGCCCCGCGTGCGGCGGGGCGCGGCTGAACCCGGCGGCACTGGCGGCCACCGTCAACGGCCGTAACATCGCCGAGTGCTCCGCCCTGCAGGTCAGCGACCTGCTCGACTTCGTCCGCGGCATCGACGCCGCCGAGGTGCGTCCCCTGACCGAGGCGCTGCGTGGCACCCTGGAGTCGATGGTGGAGATCGGCCTGGGATATCTCAGCCTGGACCGCGAGTCGGGCAGCCTCTCCGGCGGCGAGGCCCAGCGGGTGAAGATGGTCCGCCACCTCGGCTCCAGCCTCACCGACGTCACCTACGTCTTCGACGAGCCCACCACCGGACTGCACCCGCACGACGTCCAGCGGATGAACGCCCTGCTGCTGCGGCTGCGCGACAAGGGCAACACGGTGCTGGTCGTCGAGCACAAGCCGGAGGTCATCGCCATCGCCGACCACGTCGTGGACCTCGGACCCGGCGCGGGCGATGCCGGGGGACAGCTCTGTTACGCCGGTGACGTGCCCGGGCTGCGCGCTTCCGATACCCTCACCGGCCGCTGTCTCGACCACCGGGTGCCCCTGCGTGCGCAACCCCGACGGCCTCGCGGACACCTGGCGATCAGGAACGCCTCGCTGCACAACCTCAAGGACGTCAGCGTCGACATCCCGCTCGGGGTGCTCACCGCCGTCACGGGTGTCGCCGGATCCGGCAAGAGTTCCCTGATCCACGGGATGCTGGGCCACCGGGAAGGGGTCGTGGTGGTCGACCAGTCGCCGATCCGCGGCTCCCGGCGCAGCAGCCCCGCCACCTACACCAAGCTCTTCGACGGGGTACGCGCCGCCTTCGCCCGGGCCAATGGGGTGAGCGCCTCGCTGTTCAGCGCCAACTCCGAAGGAGCGTGCCCTCGCTGCAAAGGCGTCGGCGTCGTCTACACCGACCTGATGATGATGGCGGACGTGGCGTCGGTCTGCGAGGAGTGCGGGGGCCGGCGCTTCACCCCCGAGGTGCTGTCGTACACGCTCCGCGGCAGGAACATCAGCGAGGTGCTCGGGATGTCCGTGACCGAGGCCCGCGACTTCTTCCCCACCGGCCGCGTCCGTGCCTCGCTGGACCGGCTGGCCGACGTGGGGCTGGGCTACGTGGGACTGGGGCAGCCGCTCAACACGCTCTCCGGCGGGGAACGGCAGCGGCTGAAGCTGGCCGTGCACATGGCGGATCAGCCCACGGCCTACGTGCTGGACGAGCCGACGAACGGCCTGCACCTCGCCGACGTGGACAAGCTCCTCACCCTGCTGGACCGGCTCGTGGACGGCGGCAACACGGTCATCGTCATCGAGCACCACCAGGCCGTCATGGCCCACGCCGACTGGCTCATCGACCTCGGCCCGGGCGCGGGCCACGACGGTGGGCGGGTCGTCTTCACCGGCACGCCGGCCGAACTGGTGGAAACCGGTGACACGCTGACGGCACATCATCTGCGGCGGTACGTCGGCCGGGCCCGGGCACAGGCGGAGCCGGTCGGCGCGGCGCGTTGA	MSLRDDTDGTRGGPGTDPADSHDVIQVRGARENNLKRVSLDIPKRRLTVFTGVSGSGKSSLVFDTIAAESRRLINETYTAFIQSFLPALARPDVDGLHNLSAAIVVDQERMGVNSRSTVGTATDALEMLRIIFSRLSTPHVGGPGAFGFNSPDGMCRHCEGLGRVADIDVDQLVDRERSLNEGAITVPGYAVGSWNWQIFAESGLLDPDLRLRDYSPDQWHDLMHKPATKIRHNSLNVTYEGLLVKVRRTHLAKERESMQAHIRAFVERAVVFGPCPACGGARLNPAALAATVNGRNIAECSALQVSDLLDFVRGIDAAEVRPLTEALRGTLESMVEIGLGYLSLDRESGSLSGGEAQRVKMVRHLGSSLTDVTYVFDEPTTGLHPHDVQRMNALLLRLRDKGNTVLVVEHKPEVIAIADHVVDLGPGAGDAGGQLCYAGDVPGLRASDTLTGRCLDHRVPLRAQPRRPRGHLAIRNASLHNLKDVSVDIPLGVLTAVTGVAGSGKSSLIHGMLGHREGVVVVDQSPIRGSRRSSPATYTKLFDGVRAAFARANGVSASLFSANSEGACPRCKGVGVVYTDLMMMADVASVCEECGGRRFTPEVLSYTLRGRNISEVLGMSVTEARDFFPTGRVRASLDRLADVGLGYVGLGQPLNTLSGGERQRLKLAVHMADQPTAYVLDEPTNGLHLADVDKLLTLLDRLVDGGNTVIVIEHHQAVMAHADWLIDLGPGAGHDGGRVVFTGTPAELVETGDTLTAHHLRRYVGRARAQAEPVGAAR	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	227.11	gnl|BL_ORD_ID|2243|hsp_num:0	2517			306	735	tetracycline
BGC0000250.1|Nogalamycin_17 # 18406 # 19470 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.723	BGC0000250.1|Nogalamycin_17 	18406	19470	+	Loose	500	25.409	mphO	41.67	3004543	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	GTGCACGGTGAGTACAAGGTGCCCGGCGGCAAGCTCGTCGTCGTGGATGTGGACGTCGAGGACGGCGTGCTGCGGCACGTGCGGGTGGCGGGTGACTTCTTCCTGGAGCCCGACGAGGCGCTGGACGCGGTGAACGGCGCCCTGGAGGGCGCTCCTGCGGACACGGACGCGGCGGGGCTGGCCGCGCGGATCGACGCGGCGCTGCCCGCGGGGACGGTGATGTACGGCCTGACCTCGGAAGGGGTGGGCATCGCGGTGCGCCGGGCGCTGGCGCGCGCCACGGACTGGACCGACTACGACTGGCAGCTGATCCACGAGGCCCCGCAGTCGCCGGCCCTGCACATGGCGCTGGACGAGGTGCTGACCGCCGAGGTGGCAGCGGGCCGGCGGCCGCCGACGCTGCGGGTGTGGGAGTGGGGCGCCCCGGCCGTGATCATCGGCAGCTTCCAGTCGCTGCGCAACGAGGTCGACGCGGAGGGCGCCGCCCGGCACGGCGTCGAGGTGGTGCGGCGGATCTCCGGCGGCGGCGCGATGTTCGTGGAGCCCGGCAACACGATCACCTACTCGCTGTCGGTGCCCGAGTCCCTCGTCCAGGGTCTGTCCTTCCAGGACAGCTACGCCTATCTGGACGACTGGGTGCTGGGCGCCCTCGGCGATCTGGGCATCCGGGCCTGGTACCAGCCGCTGAACGACATCGCCACCGACCAGGGCAAGATCGCGGGCGCGGCGCAGAAGCGCGTGGTCGGGCCCGGCGGGGGTCCGGGTGCCGTGCTGCACCACGTGACGATGTCGTACGACATCGACGCCGACAAGATGGTCGAGGTGCTGCGGATCGGGCGGGAGAAGCTGTCCGACAAGGGCACGAAGAGCGCGAAGAAGCGGGTCGATCCGTTGCGCCGGCAGACGGGGCTGCCGCGCGAGGCCGTCATCGACCGGATGATCGAGTCCTTCCGCGCGCGCTACGGCCTGGCCGAGGGCAAGGTCACCGACGAGGAGCTGGCACGGGCGGAGGAGCTGGCCCGCACGAAGTTCGGCTCGACGGAGTGGACGGCGCGCGTGCCGTAG	MHGEYKVPGGKLVVVDVDVEDGVLRHVRVAGDFFLEPDEALDAVNGALEGAPADTDAAGLAARIDAALPAGTVMYGLTSEGVGIAVRRALARATDWTDYDWQLIHEAPQSPALHMALDEVLTAEVAAGRRPPTLRVWEWGAPAVIIGSFQSLRNEVDAEGAARHGVEVVRRISGGGAMFVEPGNTITYSLSVPESLVQGLSFQDSYAYLDDWVLGALGDLGIRAWYQPLNDIATDQGKIAGAAQKRVVGPGGGPGAVLHHVTMSYDIDADKMVEVLRIGREKLSDKGTKSAKKRVDPLRRQTGLPREAVIDRMIESFRARYGLAEGKVTDEELARAEELARTKFGSTEWTARVP	MTETSPSSPSSATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLDFRVAFARSRDWQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYPLLPGTPGLTVSADGTVEWHVDMASTEYARALGTFLAQLHTVDPEEAAATGIPSRTPSEVRGVWREDLTRVAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVEGERLSAVLDWTTASVGDPARDLMFHRSSAPPEAFAATLAAYVAGGGTLHPRLGEHAEEMFSASPLAYGLYALETGEEEHRAAAAAALDPPDAD	111.67	gnl|BL_ORD_ID|2690|hsp_num:0	3219			123	195	erythromycin
BGC0000250.1|Nogalamycin_10 # 9438 # 10730 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.702	BGC0000250.1|Nogalamycin_10 	9438	10730	+	Loose	750	190.66	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	32.6	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAAGGAATCCATCAACCGTCGCGTGGTCATCACCGGAATAGGGATCGTCGCGCCCGATGCCACCGGGGTGAAACCGTTCTGGGATCTGCTGACGGCCGGTCGCACCGCGACCCGGACCATCACCGCCTTCGATCCCTCTCCGTTCCGTTCCCGCATCGCCGCGGAATGCGATTTCGACCCGCTTGCCGAAGGGCTGACCCCCCAGCAGATCCGGCGTATGGACCGGGCCACGCAGTTCGCGGTCGTCAGCGCCCGGGAAAGCCTGGAGGACAGCGGACTCGACCTCGGCGCCCTGGACGCCTCCCGCACCGGCGTGGTCGTCGGCAGCGCGGTCGGCTGCACCACGAGCCTGGAAGAGGAGTACGCGGTCGTCAGCGACAGCGGCCGGAACTGGCTGGTCGACGACGGCTACGCCGTACCGCACCTATTCGACTACTTCGTGCCCAGCTCCATCGCCGCCGAGGTGGCACACGACCGCATCGGCGCGGAGGGCCCCGTCAGCCTCGTGTCGACCGGGTGCACCTCGGGCCTGGACGCCGTGGGCCGCGCGGCCGACCTGATCGCCGAGGGAGCGGCGGATGTGATGCTGGCCGGTGCGACCGAGGCGCCCATCTCCCCCATCACCGTGGCGTGCTTCGATGCCATCAAGGCGACCACCCCCCGCAACGACACGCCCGCCGAGGCGTCCCGTCCGTTCGACCGCACCAGGAACGGGTTCGTACTCGGCGAGGGCGCTGCCGTGTTCGTCCTGGAGGAGTTCGAACACGCGCGCCGCCGGGGCGCGCTCGTGTACGCGGAGATCGCCGGGTTCGCCACTCGCTGCAACGCCTTCCACATGACCGGTCTGCGCCCGGACGGGCGGGAGATGGCGGAGGCCATCGGGGTGGCGCTCGCCCAGGCGGGCAAGGCGCCGGCTGACGTCGACTACGTCAACGCCCACGGTTCCGGCACCCGGCAGAATGACCGTCACGAGACGGCGGCCTTCAAGCGCAGTCTCGGCGACCACGCCTACCGGGTCCCGGTCAGCAGCATCAAATCCATGATCGGGCACTCGCTGGGCGCGATCGGCTCCCTGGAGATCGCCGCCTCCGTGCTGGCCATCACACACGACGTGGTGCCGCCCACCGCCAATCTGCACGAGCCGGATCCCGAGTGCGATCTGGACTACGTGCCGCTGCGGGCGCGTGCGTGCCCGGTGGACACGGTGCTCACGGTGGGCAGCGGGTTCGGCGGTTTCCAGAGCGCCATGGTGCTGTGCGGTCCGGGCTCGCGGGGAAGGTCGGCCGCGTGA	MKESINRRVVITGIGIVAPDATGVKPFWDLLTAGRTATRTITAFDPSPFRSRIAAECDFDPLAEGLTPQQIRRMDRATQFAVVSARESLEDSGLDLGALDASRTGVVVGSAVGCTTSLEEEYAVVSDSGRNWLVDDGYAVPHLFDYFVPSSIAAEVAHDRIGAEGPVSLVSTGCTSGLDAVGRAADLIAEGAADVMLAGATEAPISPITVACFDAIKATTPRNDTPAEASRPFDRTRNGFVLGEGAAVFVLEEFEHARRRGALVYAEIAGFATRCNAFHMTGLRPDGREMAEAIGVALAQAGKAPADVDYVNAHGSGTRQNDRHETAAFKRSLGDHAYRVPVSSIKSMIGHSLGAIGSLEIAASVLAITHDVVPPTANLHEPDPECDLDYVPLRARACPVDTVLTVGSGFGGFQSAMVLCGPGSRGRSAA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	103.37	gnl|BL_ORD_ID|1968|hsp_num:0	1943			72	1239	isoniazid
